Proarrhythmogenic Echocardiographic Markers in Metabolic Syndrome: A Cross-Sectional Study

Spas Kitov1,2, Maria-Florance Kitova3, Boyan Nonchev4

  • 1Cardiology Clinic, St. George University Hospital, Faculty of Medicine, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.

Life (Basel, Switzerland)
|September 27, 2025
PubMed

Insights

Metabolic syndrome patients show impaired heart repolarization. Echocardiography

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Echocardiography

Background:

  • Metabolic syndrome is linked to cardiomyocyte changes, impaired repolarization, and increased proarrhythmogenicity.
  • Limited research exists on using speckle tracking echocardiography to assess proarrhythmogenicity in metabolic syndrome.

Purpose of the Study:

  • To evaluate the efficacy of speckle tracking echocardiography in assessing proarrhythmogenicity in patients with newly diagnosed metabolic syndrome.

Main Methods:

  • 71 metabolic syndrome patients (35-55 years) without ischemic heart disease were studied.
  • Patients underwent 48-h Holter ECG and echocardiography (GE Vivid T9).
  • Groups were divided based on arrhythmogenic load (high vs. low) from ECG data.

Main Results:

  • Significant differences in global longitudinal strain, mechanical dispersion index, and left atrium strain were observed between groups (p < 0.0001).
  • The mechanical dispersion index demonstrated optimal sensitivity and specificity among echocardiographic markers.
  • Mechanical dispersion index effectively differentiates patients with high vs. low arrhythmogenic load.

Conclusions:

  • The mechanical dispersion index is a valuable tool for assessing proarrhythmogenicity in metabolic syndrome.
  • Echocardiography, particularly the mechanical dispersion index, can aid in risk stratification for cardiac arrhythmias in metabolic syndrome patients.

Related Concept Videos

Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
329
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
215
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
492
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
411
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
725
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
540